Biotech Finance
NOTES: Guardant Health: Blood Money: Guardant's Liquid Biopsy Illusion
Marcus exposes the financial anatomy of Guardant Health's liquid biopsy engine, breaking down the catastrophic cash burn and non-GAAP illusions masking the true unit economics of early cancer screening.